An observational study in Respiratory Distress Syndrome (Neonatal), Respiratory Distress Syndrome (RDS) and Video Laryngoscopy, sponsored by University College Dublin. Recruiting at 16 sites in 9 countries. Open to participants aged 0 Minutes to 28 Days. Per ClinicalTrials.gov, last updated 2025-02-20.
Sponsored by University College Dublin · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Many premature babies have breathing difficulty after birth and receive help with a breathing machine (nasal continuous positive airway pressure, NCPAP). Some of the babies whose breathing gets worse despite NCPAP are treated with surfactant, a medication that is given directly into their windpipe (trachea). Some of the babies who are given surfactant get it through a ventilation tube (endotracheal tube, ETT), while others get it through a thin catheter that is too small for ventilation. When doctors insert a tube or a thin catheter into the windpipe of a baby, they use an instrument called a laryngoscope, which has a light at its tip, to identify the entrance. Most often doctors look directly into the baby's mouth with a standard laryngoscope to identify the entrance to the windpipe. However, newer video laryngoscopes have a camera along with the light at their tip, which displays a picture of the entrance to the windpipe on a screen. In a study performed at one hospital, doctors inserted an ETT first time more often when they used a video laryngoscope.
The investigators are doing a study at many hospitals where doctors usually use a standard laryngoscope to insert tubes and thin catheters into a baby's trachea by looking directly into the mouth. Each hospital will switch one-by-one to using a video laryngoscope when inserting a tube. The investigators will compare the information we collect to see if more babies who have a tube inserted first time without falls in their oxygen levels or heart rate with a video laryngoscope. The investigators will also collect information on babies who have a thin catheter inserted to compare whether doctors use fewer attempts when they use a video laryngoscope.
Many newborn infants have breathing difficulty after birth, particularly when they are born prematurely. Many of these infants are supported with nasal continuous positive airway pressure (NCPAP). Some of the infants deteriorate despite treatment with NCPAP and have a thin catheter inserted into their trachea for the administration of surfactant, which is then immediately removed (often referred to as "less-invasive surfactant administration" or LISA). Insertion of a thin catheter is usually performed by doctors who are experienced at intubation (i.e. inserting endotracheal tubes, ETTs). They look directly into the the infants mouth using a standard laryngoscope to identify the opening of the airway (i.e. perform direct laryngoscopy). More recently video laryngoscopes have been developed. These devices display a magnified image of the airway on a screen that can be viewed indirectly by the doctor attempting to insert the ETT or thin catheter, and also by others. A single centre study reported that more infants were successfully intubated at the first attempt when doctors performed indirect video laryngoscopy compared to direct laryngoscopy.
It is possible to independently verify when a doctor has correctly inserted and ETT, for example by detecting carbon dioxide coming out of the tube or seeing condensation in the tube during exhalation, or by hearing breath sounds by listening to the chest during positive pressure inflations. It is not possible to independently verify whether a doctor has correctly inserted a thin catheter under direct laryngoscopy, by these or other means. The standard (and to date only) way of confirming that a thin catheter has been correctly inserted is to rely on the report of the operator. Video laryngoscopy, in contrast, allows the independent verification of the tip of a thin catheter by one or more people observing the screen.
The investigators are performing NEU-VODE, a stepped wedge cluster randomised study of the introduction of video laryngoscopy versus direct laryngoscopy for the intubation of newborn infants. Alongside this study, the investigators are performing a study of infants who have a thin endotracheal catheter inserted under video laryngoscopy versus direct laryngoscopy. As it is not possible to measure the outcome of successful insertion of the thin catheter equally in both groups, this is a prospective observational cohort study. The investigators will record information on infants who have a thin catheter inserted into the trachea for the purpose of surfactant administration at centres participating in the NEU-VODE study. The type of laryngoscope used for thin catheter insertion attempts will not be mandated; instead, the investigators will compare the information of groups within the cohort who have their first attempt made using the video laryngoscope to the group who have their first attempt made with direct laryngoscopy.
378 studies on the registry are indexed under Pulmonary Atelectasis; 91 are open to participants now.
This study's planned enrollment of 600 is above the median of 78 across 101 observational studies indexed under Pulmonary Atelectasis.
Browse Pulmonary Atelectasis studies →University College Dublin is the lead sponsor of 114 studies on the registry; 33 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Newborn infants (\<28 days old) who have a thin catheter inserted into their trachea for the purpose of surfactant administration ("less-invasive surfactant administration", LISA)
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Video laryngoscopy used to insert thin endotracheal catheter
Device: Video laryngoscopy used to insert thin endotracheal catheter
Direct laryngoscopy used to insert thin endotracheal catheter
Device: Direct laryngoscopy used to insert thin endotracheal catheter
Video laryngoscopy used to insert thin endotracheal catheter
Direct laryngoscopy used to insert thin endotracheal catheter
Successful thin catheter insertion at the first attempt without physiologic instability
Successful thin catheter insertion at the first attempt without fall in SpO2 \>20% from baseline or HR\<100bpm
Time frame: At 30 minutes from the start of the insertion attempt
Successful thin catheter insertion at the first attempt
Successful thin catheter insertion at the first attempt
Time frame: At 30 minutes from the start of the insertion attempt
Physiologic instability during first thin endotracheal catheter insertion attempt
Fall in SpO2\>20% from baseline or HR\<100bpm during first thin endotracheal catheter insertion attempt
Time frame: At 30 minutes from the start of the insertion attempt
Duration of laryngoscopy of first insertion attempt
Interval from introduction of laryngoscopy blade to its removal (seconds)
Time frame: At 30 minutes from the start of the insertion attempt
Number of attempts taken to insert thin endotracheal catheter
Number of attempts taken to insert thin endotracheal catheter
Time frame: At 30 minutes from the start of the insertion attempt
Time taken to insert thin endotracheal catheter on successful attempt
Interval from insertion of laryngoscope blade to insertion of thin endotracheal catheter on successful attempt (seconds)
Time frame: At 30 minutes from the start of the insertion attempt
Total laryngoscopy time to successful insertion
Sum of all intervals from introduction of laryngoscope blade to removal for unsuccessful insertion attempts; plus interval from introduction of blade to catheter insertion for successful attempt in seconds
Time frame: At 30 minutes from the start of the insertion attempt
Lowest oxygen saturation (SpO2) during the procedure
Lowest oxygen saturation (SpO2) during the procedure
Time frame: At 30 minutes from the start of the insertion attempt
Lowest heart rate (HR) during the procedure
Lowest heart rate (HR) during the procedure
Time frame: At 30 minutes from the start of the insertion attempt
Oral trauma
Oral trauma reported by clinicians
Time frame: At 1 hour from the start of the insertion attempt
Chest compressions
Chest compressions
Time frame: At 1 hour from the start of the insertion attempt
Adrenaline
Adrenaline
Time frame: At 1 hour from the start of the insertion attempt
Further thin catheter surfactant treatment
Further thin catheter surfactant treatment
Time frame: Within 72 hours of insertion attempt
Endotracheal intubation and ventilation
Endotracheal intubation and ventilation
Time frame: Within 72 hours of insertion attempt
Surfactant treatment via endotracheal tube
Surfactant treatment via endotracheal tube
Time frame: Within 72 hours of insertion attempt
Plan to share: Yes — Data will be shared o consideration of reasonable request to investigators
Time frame: Study publication, for 2 years
No publications or documents are linked to this record.
Started Jan 2025 (actual). Primary completion is estimated for Dec 2025, 11 months after the start.
Of 58 non-industry observational studies under Pulmonary Atelectasis, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 19. This study's planned 11 months is close to that.
Counting every sponsor, half of 58 studies reached it within 11 months; a quarter within 6 and three quarters within 19.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.